TALIMOGENE LAHERPAREPVEC (Imlygic) Nursing Considerations

What is the generic name?

TALIMOGENE LAHERPAREPVEC

What is the Trade Name for TALIMOGENE LAHERPAREPVEC?

Imlygic

What are the Indications for TALIMOGENE LAHERPAREPVEC?

• 1 INDICATIONS AND USAGE IMLYGIC is a genetically modified oncolytic viral therapy indicated for the local treatment of unresectable cutaneous, subcutaneous, and nodal lesions in patients with melanoma recurrent after initial surgery. IMLYGIC is a genetically modified oncolytic viral therapy indicated for the local treatment of unresectable cutaneous, subcutaneous, and nodal lesions in patients with melanoma recurrent after initial surgery. Limitations of use : IMLYGIC has not been shown to improve overall survival or have an effect on visceral metastases. ( 1 ) Limitations of use : IMLYGIC has not been shown to improve overall survival or have an effect on visceral metastases.

References: https://open.fda.gov/